𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor-β1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines

✍ Scribed by Eirik Helseth; Are Dalen; Geirmund Unsgaard; Toril Skandsen; Jan GrØNdahl-Hansen; Leif R. Lund

Book ID
114822464
Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
584 KB
Volume
96
Category
Article
ISSN
0365-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transforming growth factor β1, urokinase
Transforming growth factor β1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa
✍ Fatima S. Pasini; M. Mitzi Brentani; Luiz P. Kowalski; Miriam H. H. Federico 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Background: A balance between urokinase-type plasminogen activator (upa) and its main inhibitor type-1 (pai-1) appears to be important for cancer invasive behavior. since upa/pai-1 system seems to be regulated by transforming growth factor beta1 (tgfbeta1) in different cell types, our aim was to

Type beta transforming growth factor and
Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line
✍ Eirik Helseth; Are Dalen; Geirmund Unsgaard; Randi Vik 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 506 KB

In the human glioblastoma cell line, T-MG1, plasminogen activator activity (PA-activity) was demonstrated by using the chromogenic substrate S-2251. Using monoclonal antibodies against human urokinase type PA (u-PA) and human tissue type PA (t-PA), only u-PA activity was found in T-MG1 cell extracts

Growth state-dependent regulation of pla
Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-β1
✍ Jeffrey R. Boehm; Stacie M. Kutz; E. Helene Sage; Lisa Staiano-Coico; Paul J. Hi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

Transit of serumstimulated normal rat kidney (NRK) epthelial cells through the first division cycle after release from quiescence (G 0 ) provided a model system to assess the kinetics and mechanisms underlying PAI-1 expression in a growth "activated" phenotype. PAI-1 mRNA transcripts increased by mo

Multidrug transport in human glioblastom
Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type β1, β2, and β1.2
✍ Ph.D. H. J. Schluesener 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

The transforming growth factors type PI, p2, and p,.2 suppress multidrug transport in human pat-1 glioblastoma cells and even in cells that strongly overexpress mdr genes and are resistant to inhibition of multidrug transport by chemosensitizers. Thus, inhibition of multidrug transport by cytokines